Quinolinone derivatives

US7598268B2 · kind B2 · utility

Assignee

• Novartis Vaccines and Diagnostics, Inc. · US

Inventors

• Paul A. Renhowe · Danville, US
• Sabina Pecchi · Oakland, US
• Timothy Machajewski · Martinez, US
• Cynthia Shafer · El Sobrante, US
• Clarke B. Taylor · Ann Arbor, US
• William McCrea · Berkeley, US
• Christopher McBride · Oakland, US
• Elisa Jazan · Richmond, US

Key dates

• Filing date: Jul 8, 2004
• Grant date: Oct 6, 2009
• Expiry date: Jul 8, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Organic compounds having the formula I are provided where the variables have the values described herein.Pharmaceutical formulations include the organic compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and may be prepared by mixing the organic compounds or pharmaceutically acceptable salts of the organic compounds with a carrier and water. A method of treating a patient includes administering a pharmaceutical formulation according to the invention to a patient in need thereof.